![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Madrigal Pharmaceuticals Inc | NASDAQ:MDGL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 274.69 | 274.02 | 294.00 | 1 | 12:54:02 |
The equity awards were granted as an inducement material to the employees’ acceptance of employment with the company. The new employees received, in the aggregate, (1) 28,246 restricted stock units, which vest in a 25% increment on each of the first through fourth anniversaries of the grant date and (2) stock options to acquire 10,385 shares of common stock, which vest as follows (i) 25% of such new employee’s total option shares shall vest under the option on the first anniversary of the date of grant and (ii) 6.25% of such new employee’s total option shares shall vest under the option on each quarterly anniversary following the first anniversary of the date of grant. All awards described under (1) and (2) above shall be subject to each such employee’s continued employment as of the vesting date. The exercise price per share for the stock options described above is $146.00.
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a liver-directed THR-β agonist oral therapy that is designed to target key underlying causes of NASH. For more information, visit www.madrigalpharma.com.
Investor Contact Alex Howarth, Madrigal Pharmaceuticals, Inc., IR@madrigalpharma.com
Media ContactChristopher Frates, Madrigal Pharmaceuticals, Inc., media@madrigalpharma.com
1 Year Madrigal Pharmaceuticals Chart |
1 Month Madrigal Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions